Workflow
申万宏源(000166) - 2025 Q3 - 季度财报
2025-10-30 11:45
2025 年第三季度报告 证券代码:000166 证券简称:申万宏源 公告编号:2025-93 申万宏源集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.公司董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、 准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法 律责任。 2.公司法定代表人、执行董事、总经理黄昊先生,财务总监任全胜女士及计 划财务部负责人刘智祥先生声明:保证季度报告中财务信息的真实、准确、完整。 3.本季度报告经公司第六届董事会第十一次会议审议通过。会议应参加表决 董事 11 人,实际参加表决董事 11 人。 4.公司第三季度报告是否经过审计 □是 √否 5.审计师发表非标意见的事项 □适用 √不适用 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 √是 □否 单位:元 币种:人民币 1 2025 年第三季度报告 | 项目 | 本报告期 | 上年同期 | | 本报告期 比上年同 | 期增减(%) 年初至报告期末 ...
交通银行(601328) - 2025 Q3 - 季度财报
2025-10-30 11:40
交通银行股份有限公司(以下简称"交通银行"或"本行")董事会及全体董事保证本 公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和 完整性承担法律责任。 股票代码:601328 股票简称:交通银行 交通银行股份有限公司 2025 年第三季度报告 重要内容提示: 本行董事会及董事、高级管理人员保证季度报告内容的真实、准确、完 整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 本行第十一届董事会第二次会议于 2025 年 10 月 30 日审议批准了本行及 附属公司("本集团")2025 年第三季度报告。 本行负责人任德奇先生、主管会计工作负责人周万阜先生及会计机构负 责人马泽泉先生保证季度报告中财务信息的真实、准确、完整。 本季度报告中的财务报表未经审计。 一、主要财务数据 (一)主要会计数据和财务指标 截至 2025 年 9 月 30 日("报告期末"),本集团按照中国会计准则要求编 制的主要会计数据和财务指标如下: 1 | 主要会计数据 | 2025 年 9 | 月 30 日 | 2024 年 12 月 31 日 | 增减(%) | | --- | --- ...
川大智胜(002253) - 2025 Q3 - 季度财报
2025-10-30 11:40
Financial Performance - The company's operating revenue for the third quarter was ¥22,115,731.66, a decrease of 44.00% compared to the same period last year[6]. - The net profit attributable to shareholders was -¥31,724,557.32, representing a decline of 218.88% year-on-year[6]. - The net loss attributable to shareholders for the first three quarters reached -¥64,602,546.53, a decline of 138.95% compared to the same period last year[6]. - Total operating revenue for the period was CNY 76,630,815.88, a decrease of 39.5% compared to CNY 126,568,043.29 in the previous period[27]. - Net loss for the period was CNY 99,060,292.10, compared to a net loss of CNY 29,569,681.91 in the previous period, representing an increase in loss of 235.5%[28]. - Basic and diluted earnings per share were both CNY -0.2863, compared to CNY -0.1198 in the previous period[28]. Cash Flow - The net cash flow from operating activities was -¥16,449,559.31, a decrease of 259.81% compared to the previous year[6]. - Net cash flow from operating activities was -$16.45 million, worsening from -$4.57 million year-over-year[30]. - Cash inflow from investment activities was $1.51 million, down from $2.45 million[30]. - Cash outflow from investment activities reached $57.62 million, significantly higher than $13.13 million last year[30]. - Net cash flow from investment activities was -$56.12 million, compared to -$13.13 million previously[30]. - Cash inflow from financing activities totaled $63.88 million, up from $40.50 million year-over-year[31]. - Net cash flow from financing activities was -$14.08 million, an improvement from -$25.90 million year-over-year[31]. - Ending cash and cash equivalents balance was $48.87 million, down from $94.71 million at the beginning of the period[31]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,466,968,576.90, a slight increase of 0.21% from the end of the previous year[6]. - Total liabilities amounted to CNY 406,450,355.43, up from CNY 307,398,719.85 in the previous period[26]. - Total equity attributable to shareholders of the parent company decreased to CNY 1,064,438,043.76 from CNY 1,129,040,590.29[26]. - Non-current liabilities totaled CNY 60,966,706.72, down from CNY 103,246,134.24 in the previous period[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 30,995[19]. - The largest shareholder, You Zhisheng, holds 9.13% of shares, equating to 20,589,033 shares[19]. - The top ten shareholders hold a combined total of 43.37% of the company's shares, indicating a concentrated ownership structure[20]. Research and Development - Research and development expenses increased by 40.38% year-on-year, amounting to an additional ¥1,089,690.00, reflecting increased investment in R&D activities[14]. - Research and development expenses rose to CNY 37,883,643.82, an increase of 40.5% from CNY 26,986,752.05 in the prior period[27]. Acquisitions and Investments - The company reported a significant increase in goodwill of ¥62,677,200.00, a growth of 2,682.37%, primarily due to the acquisition of Chengdu Hanbode Technology Co., Ltd.[8]. - The company acquired a 70% stake in Chengdu Hanbode Information Technology Co., Ltd. for cash, which will be consolidated into the financial statements[23]. - The company plans to establish Sichuan Zhisheng Shengyuan Technology Co., Ltd. with a registered capital of 10 million CNY, holding a 51% stake[21]. Risk Factors - The company is under a delisting risk warning due to financial performance criteria not being met, with potential implications for stock trading in 2025[24].
中装建设(002822) - 2025 Q3 - 季度财报
2025-10-30 11:40
Financial Performance - The company's operating revenue for the third quarter was ¥194,789,384.79, a decrease of 66.56% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥109,680,680.96, representing an increase in loss of 68.76% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥106,415,957.76, a 69.68% increase in loss compared to the previous year[5]. - The basic and diluted earnings per share were both -¥0.31, reflecting a 36.73% increase in loss year-on-year[5]. - Total operating revenue for the current period is ¥603,797,882.74, a significant decrease from ¥1,873,677,132.31 in the previous period, representing a decline of approximately 67.8%[38]. - Operating profit for the current period is reported at -¥495,533,174.95, compared to -¥785,360,043.13 in the previous period, showing an improvement of approximately 36.9%[39]. - Net profit for the current period stands at -¥521,278,206.62, which is an improvement from -¥792,073,695.94 in the previous period, reflecting a reduction in losses of about 34.2%[39]. - The net profit attributable to the parent company was -¥506,066,707.19, compared to -¥795,295,270.30 in the previous period, indicating an improvement[40]. - The total comprehensive income attributable to the parent company was -¥506,066,707.19, compared to -¥795,295,270.30 in the previous period[40]. - The basic and diluted earnings per share were both -¥0.69, an improvement from -¥1.11 in the previous period[40]. Cash Flow and Assets - The company's cash flow from operating activities showed a net outflow of -¥40,429,043.03, with an increase in outflow of 83.15% year-on-year[5]. - Cash inflows from operating activities totaled ¥859,169,145.21, down from ¥2,214,485,069.23 in the previous period[41]. - The net cash flow from operating activities was -¥40,429,043.03, compared to -¥239,880,079.32 in the previous period, showing a reduced loss[42]. - The net cash flow from investing activities was -¥12,700,041.11, compared to -¥2,191,690.95 in the previous period[42]. - The net cash flow from financing activities was -¥10,634,458.66, compared to -¥125,898,117.41 in the previous period[43]. - The cash and cash equivalents at the end of the period were ¥101,237,161.27, down from ¥138,908,591.26 in the previous period[43]. - The company has a total of 151,028,758.91 yuan in cash at the end of the reporting period, down from 236,892,033.01 yuan at the beginning[34]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,126[29]. - The largest shareholder, Zhuang Xiaohong, holds 10.34% of shares, totaling 99,413,198 shares, which are frozen[29]. - The second-largest shareholder, Zhuang Zhannuo, holds 5.41% of shares, totaling 51,959,470 shares, which are also frozen[29]. - The top ten shareholders hold a significant portion of shares, with the largest three shareholders alone accounting for over 17% of total shares[29]. Restructuring Efforts - The company is in the process of selecting restructuring investors to protect the interests of all creditors[30]. - A restructuring investment agreement has been signed with Shanghai Hengcan Enterprise Management Consulting Co., Ltd. and Shanghai Kangheng Environment Co., Ltd.[31]. - The first creditors' meeting for the restructuring was held on October 14, 2025[32]. - The company has received a court ruling to accept the restructuring application, indicating ongoing financial difficulties[31]. - The company is actively engaging with creditors to facilitate the restructuring process and maximize recovery[30]. Research and Development - The company's research and development expenses decreased by 90.13% compared to the previous year, indicating reduced investment in R&D projects[21]. - Research and development expenses for the current period are reported at ¥3,797,919.47, a substantial decrease from ¥38,462,022.16 in the previous period, indicating a reduction of approximately 90.1%[39]. Operational Costs - The company experienced a 71.97% decrease in operating costs, attributed to a reduction in business volume[19]. - Total operating costs for the current period amount to ¥879,750,099.25, down from ¥2,496,818,809.79 in the previous period, indicating a reduction of about 64.8%[39]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,780,748,442.88, a decrease of 5.41% from the end of the previous year[5]. - Total current assets amount to ¥4,261,328,318.57, a decrease from ¥4,582,547,569.58 in the previous period, representing a decline of approximately 7.0%[36]. - Total liabilities are reported at ¥4,437,839,782.02, down from ¥5,079,353,723.68 in the previous period, indicating a reduction of about 12.7%[36]. - The company's equity attributable to shareholders increased to ¥1,419,842,127.37 from ¥1,094,830,790.13, marking an increase of approximately 29.6%[36]. - The company has reported a significant increase in accounts receivable, totaling ¥1,488,660,584.60, compared to ¥1,686,234,211.02 in the previous period, reflecting a decrease of about 11.7%[36]. - The company’s inventory has increased to ¥667,089,346.22 from ¥524,028,316.24, representing an increase of about 27.4%[36]. Other Information - The company reported a decrease in cash inflows from sales of goods and services, totaling ¥740,917,628.93 compared to ¥2,013,486,823.81 in the previous period[41]. - The company did not conduct any audited financial report for the third quarter[43].
皓宸医疗(002622) - 2025 Q3 - 季度财报
2025-10-30 11:40
Financial Performance - The company's operating revenue for Q3 2025 was ¥213,255,740.57, a decrease of 15.72% compared to the same period last year[5] - The net profit attributable to shareholders was -¥2,658,745.89, representing a decline of 120.54% year-on-year[5] - The basic earnings per share were -¥0.0031, down 120.13% from the previous year[5] - Total operating revenue decreased to ¥526,891,688.79 from ¥635,030,298.87, representing a decline of approximately 17.1% year-over-year[30] - Net profit for the period was a loss of ¥31,025,238.07 compared to a profit of ¥28,681,678.30 in the previous period, indicating a substantial decline[31] - Total comprehensive income for the period was -¥38,291,121.64, a significant drop from ¥30,221,773.21 in the prior year[32] - The company experienced a total loss of ¥28,257,351.48 in profit before tax, compared to a profit of ¥31,302,613.93 in the previous period[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,453,688,194.93, a decrease of 2.92% from the end of the previous year[5] - The company's total liabilities as of September 30, 2025, were CNY 1,042,562,022.36, down from CNY 1,054,436,349.33, indicating a reduction of about 1.1%[29] - The company's cash and cash equivalents decreased to CNY 125,287,409.13 from CNY 147,693,180.87, representing a decline of approximately 15.2%[27] - Accounts receivable fell to CNY 27,073,537.72 from CNY 39,169,433.88, a decrease of about 30.9%[27] - Inventory increased to CNY 57,657,756.69 from CNY 50,753,348.55, marking an increase of approximately 13.5%[27] - The company's total equity decreased to CNY 411,126,172.57 from CNY 443,047,294.21, reflecting a decline of about 7.2%[29] Research and Development - Research and development expenses increased by ¥606,000, or 108.60%, compared to the same period last year[9] - Research and development expenses increased significantly to ¥11,646,500.56 from ¥5,583,042.65, marking a rise of approximately 108.5% year-over-year[31] Cash Flow - The company reported a net cash flow from operating activities of -¥10,146,191.88, a decrease of 123.56% year-to-date[5] - The net cash flow from operating activities was negative at -¥10,146,191.88, a decrease from a positive cash flow of ¥43,066,291.87 in the prior year[34] - Cash and cash equivalents at the end of the period stood at ¥110,286,409.13, down from ¥152,382,007.24, reflecting a decrease of approximately 27.6%[34] Legal and Regulatory Issues - The company has disclosed multiple legal proceedings and updates related to the Jin Haitang case, with various court documents filed from 2020 to 2024[15] - The company has reported that it is in communication with the executing party and the Shanghai Financial Court regarding the Jin Haitang asset management case[16] - The company has faced asset freezes due to disputes with Zhejiang Zheshang Asset Management Co., Ltd. and Wenzhou Bank Co., Ltd.[21] - The company has not yet fulfilled its repayment obligations to Zhejiang Zheshang Asset Management Co., Ltd. and is exploring solutions to address its debt issues[21] - The company has disclosed that it has received a debt transfer notification from Zhejiang Zheshang Asset Management Co., Ltd. to Zhejiang Zheba Xianv Lake Enterprise Management Partnership[19] - The company has reported on the freezing of bank accounts and assets of its subsidiaries, with updates provided on various dates in 2023[18] Shareholder and Equity Changes - The total equity attributable to shareholders was ¥364,359,479.58, down 8.46% from the end of the previous year[5] - The number of ordinary shareholders at the end of the reporting period was 46,198[12] - The first major shareholder, 汇垠日丰, has become the sole trustee of a specific asset management plan, indicating a shift in control dynamics[23] - The company is actively preparing a detailed equity change report following recent court rulings affecting its control structure[24] - The company is actively seeking to negotiate with creditors regarding debt relief, extension, installment repayment, and financing replacement options[21] Investor Advisory - The company reminds investors to be aware of investment risks and to invest rationally[17] - Investors are advised to remain cautious and rational in their investment decisions due to ongoing uncertainties surrounding the company's control and financial performance[25]
富创精密(688409) - 2025 Q3 - 季度财报
2025-10-30 11:40
沈阳富创精密设备股份有限公司 2025 年第三季度报告 证券代码:688409 证券简称:富创精密 沈阳富创精密设备股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误 导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:万元 币种:人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 100,638.04 | 24.46 | 273,0 ...
兰州银行(001227) - 2025 Q3 - 季度财报
2025-10-30 11:40
证券代码:001227 证券简称:兰州银行 公告编号:2025-046 兰州银行股份有限公司 BANK OF LANZHOU CO., LTD. (股票代码:001227) 2025 年第三季度报告 2025 年 10 月 2025 年第三季度报告 重要内容提示 1.兰州银行股份有限公司(以下简称"本行")董事会、监事会及董事、监事、高级管 理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承 担个别和连带的法律责任。 2.本行董事、监事、高级管理人员是否存在对季度报告内容存在异议或无法保证其真实、 准确、完整的情况 7.审计师发表非标意见的事项 适用 不适用 8.本报告除特别注明外,为本行合并口径数据,均以千元为单位,可能因四舍五入而存 在尾差。 1 2025 年第三季度报告 是 否 3.本报告所载财务数据及指标按照中国企业会计准则编制,除特别说明外,均为本行及 控股子公司甘肃兰银金融租赁股份有限公司的合并报表数据,货币币种为人民币。 4.本行第六届董事会第五次会议审议通过了《兰州银行股份有限公司 2025 年第三季度报 告》。会议应出席董事 10 名,实际出席董事 10 名。本 ...
海天股份(603759) - 2025 Q3 - 季度财报
2025-10-30 11:40
Financial Performance - The company's operating revenue for the third quarter reached ¥1,042,859,192.69, an increase of 218.44% compared to the same period last year[5] - The total profit for the quarter was ¥62,107,364.21, reflecting a growth of 9.35% year-on-year[5] - Net profit attributable to shareholders was ¥42,549,554.61, up by 3.21% compared to the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥40,400,068.57, an increase of 7.03% year-on-year[5] - Total operating revenue for the first three quarters of 2025 reached CNY 2,041,177,926.45, a significant increase of 94.8% compared to CNY 1,048,923,454.64 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was CNY 120,356,411.34, a decrease of 24.8% from CNY 160,038,052.49 in the same period of 2024[21] - Earnings per share for the first three quarters of 2025 were CNY 0.23, down from CNY 0.31 in the previous year[22] Assets and Liabilities - The company's total assets increased by 35.18% to ¥8,938,774,209.84 compared to the end of the previous year[6] - Total current assets as of September 30, 2025, amount to ¥3,193,008,629.41, an increase from ¥1,807,426,579.99 in the previous year[17] - Accounts receivable increased to ¥1,509,837,797.78 from ¥980,726,379.95 year-over-year[17] - Total liabilities increased to CNY 5,838,331,536.35 in 2025 from CNY 3,631,789,095.23 in 2024, reflecting a growth of 60.7%[19] - The company's total non-current liabilities reached CNY 3,268,023,824.94 in 2025, compared to CNY 1,938,219,026.81 in 2024, marking an increase of 68.7%[19] Cash Flow - The cash flow from operating activities showed a negative net amount of ¥306,431,514.54, a decline of 235.74% year-to-date[6] - Cash generated from operating activities in the first three quarters of 2025 was CNY 1,672,597,390.26, compared to CNY 855,603,083.23 in the same period of 2024[23] - The net cash flow from operating activities was -306,431,514.54, compared to 225,753,450.87 in the previous period, indicating a significant decline[24] - Total cash inflow from financing activities reached 3,049,040,440.90, up from 752,750,418.37, reflecting a strong increase in financing efforts[25] - The net cash flow from investing activities was -594,501,539.93, worsening from -329,827,456.10, highlighting increased investment outflows[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 25,417[13] - The largest shareholder, Sichuan Haitan Investment Co., Ltd., holds 267,768,008 shares, accounting for 57.99% of total shares[13] Operational Insights - The significant increase in revenue is attributed to the acquisition of the photovoltaic silver paste division from Heraeus, which boosted the new energy materials business[10] - The net profit decline of 34.99% is primarily due to reduced sewage pricing income compared to the same period last year[11] - The company is currently in a growth phase for its new energy materials segment, leading to an increase in accounts receivable and negative operating cash flow[11] - The company reported a significant increase in inventory, rising to ¥146,189,620.73 from ¥28,991,812.65 year-over-year[17] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending[14] - There are no other important reminders regarding the company's operational situation during the reporting period[15] Expenses - Total operating costs for the first three quarters of 2025 were CNY 1,912,165,924.97, up 128.9% from CNY 835,499,746.82 in the previous year[20] - Research and development expenses for the first three quarters of 2025 were CNY 54,571,965.31, significantly higher than CNY 1,692,599.31 in the same period of 2024[20] - The company reported a total of CNY 99,515,648.60 in financial expenses for the first three quarters of 2025, up from CNY 69,353,025.63 in the previous year[21] - The company paid 1,513,897,790.66 for goods and services, a substantial increase from 328,830,182.49, reflecting higher operational costs[24]
牧原股份(002714) - 2025 Q3 - 季度财报
2025-10-30 11:40
Revenue and Profitability - Revenue for Q3 2025 was CNY 35.33 billion, a decrease of 11.48% year-over-year[6] - Net profit attributable to shareholders was CNY 4.25 billion, down 55.98% compared to the same period last year[6] - Basic earnings per share decreased by 56.42% to CNY 0.78[6] - Total operating revenue for the current period reached ¥111.79 billion, a 15.5% increase from ¥96.78 billion in the previous period[20] - Net profit for the current period was ¥15.11 billion, representing a 34.5% increase compared to ¥11.25 billion in the previous period[21] - Basic earnings per share rose to ¥2.74, up from ¥1.94 in the previous period, reflecting a 41.3% increase[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 180.76 billion, a decrease of 3.67% from the end of the previous year[6] - As of September 30, 2025, the total assets amount to RMB 180.76 billion, a decrease from RMB 187.65 billion at the beginning of the period, reflecting a reduction of approximately 3.8%[18][19] - The total current liabilities decreased from RMB 85.48 billion to RMB 76.80 billion, representing a decline of about 10.5%[19] - The total liabilities decreased from RMB 110.11 billion to RMB 100.32 billion, indicating a reduction of approximately 8.0%[19] - The company reported a significant increase in other payables, rising from RMB 8.35 billion to RMB 11.84 billion, an increase of approximately 42.5%[19] Cash Flow - The company reported a net cash flow from operating activities of CNY 28.58 billion, a decrease of 2.05% year-to-date[6] - Cash flow from operating activities generated ¥28.58 billion, slightly down from ¥29.18 billion in the previous period[23] - Cash inflow from investment activities was ¥8.58 billion, compared to ¥7.10 billion in the previous period, marking a 20.8% increase[24] - Cash outflow from investment activities totaled ¥17.08 billion, down from ¥19.77 billion year-over-year[24] - The net cash outflow from financing activities was -15,656,261,351.92, compared to -14,540,648,643.14 in the previous period, indicating a worsening trend[25] - The total cash and cash equivalents at the end of the period increased to 17,268,736,105.83 from 15,745,131,519.77, reflecting a net increase of 4,424,184,492.75[25] Equity and Share Repurchase - The total equity attributable to shareholders increased by 6.72% to CNY 76.87 billion compared to the end of the previous year[6] - The total equity attributable to the parent company increased from RMB 72.03 billion to RMB 76.87 billion, reflecting an increase of approximately 6.0%[19] - The total amount for the share repurchase plan announced on September 27, 2024, is between RMB 30 billion and RMB 40 billion, with a target to repurchase approximately 69.59 million shares from October 18, 2024, to August 26, 2025[16] - The company repurchased a total of 41.87 million shares in the previous buyback program, which was completed by September 2025[15] Investments and Future Plans - Investment income increased by 127.15% year-over-year, primarily due to increased returns from joint ventures[12] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[20] Accounting and Reporting - The third quarter financial report was not audited, which may affect the reliability of the reported figures[26] - The company will implement new accounting standards starting in 2025, which may impact future financial reporting[27]
海创药业(688302) - 2025 Q3 - 季度财报
2025-10-30 11:40
证券代码:688302 证券简称:海创药业 海创药业股份有限公司 2025 年第三季度报告 海创药业股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 单位:元 币种:人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 10,184,670.01 | 不适用 | 23,351 ...